文献速递浆细胞疾病

CD138表面表达动态调控骨髓瘤生长与播散的切换

Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination.
PubMed 文献 · Leukemia · 2019-08-22

本研究利用Vk*MYC小鼠骨髓瘤模型发现,CD138高表达亚群增殖活跃、凋亡少且IL-6R信号增强,成瘤能力更强;CD138阴性亚群运动性强、易播散至其他骨骼。中和CD138可快速触发骨髓瘤细胞迁移和血管内渗,增加播散;阻断CD138可增强硼替佐米敏感性并缩小肿瘤。CD138表面表达通过内吞 trafficking 响应血清水平快速循环,动态调控生长与播散的切换。

要点

  • CD138高表达骨髓瘤细胞增殖活跃、凋亡少、成瘤能力强。
  • CD138阴性细胞运动性强、易播散至其他骨骼。
  • 阻断CD138增强硼替佐米敏感性并缩小肿瘤。

核心结论

  • CD138表面表达动态调控骨髓瘤生长与播散的切换,响应营养条件。

研究设计与样本

  • 使用Vk*MYC小鼠骨髓瘤模型,CD138表达随肿瘤大小而异质表达。

主要发现

  • CD138高表达亚群较CD138阴性亚群增殖高、凋亡少、IL-6R信号增强,成瘤更好。
  • CD138阴性细胞体外和体内运动性更强,更易播散至其他骨骼。
  • 中和CD138快速触发体内骨髓瘤细胞迁移和血管内渗,增加播散。
  • 鼠和人类骨髓瘤细胞通过内吞 trafficking 响应血清水平快速循环CD138表面表达。
  • 阻断CD138增强骨髓瘤对硼替佐米敏感性,较单用硼替佐米显著缩小肿瘤。

临床怎么用

  • 靶向CD138可能增强硼替佐米疗效,但需注意中和CD138可能促进播散。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The canonical plasma cell marker CD138 (syndecan-1) is highly expressed on the myeloma cell surface, but its functional role in vivo is unclear, as well as the ontogeny of CD138-high and CD138-negative (neg) myeloma cells. In this study we used an in vivo murine Vk*MYC myeloma model where CD138 is heterogeneously expressed depending on tumor size. We find that in comparison to CD138-neg myeloma cells, the CD138-high subset of myeloma cells is highly proliferative, less apoptotic, and enhanced IL-6R signaling, which is known to promote survival. In addition CD138-high myeloma engrafts better than its CD138-neg counterpart. In contrast, CD138-neg cells are more motile both in vitro and in vivo, and more readily disseminate and spread to other bones in vivo than CD138-high subset. Neutralizing CD138 rapidly triggers migration of myeloma cells in vivo and leads to intravasation, which results in increased dissemination to other bones. Both murine and human myeloma cells can rapidly recycle CD138 surface expression through endocytic trafficking, in response to serum levels. Blocking CD138 enhances myeloma sensitivity to bortezomib chemotherapy and significantly reduces tumor size compared to bortezomib treatment alone. Thus, our data show that CD138 surface expression dynamically regulates a switch between growth vs. dissemination for myeloma, in response to nutrient conditions.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Akhmetzyanova I, McCarron MJ, Parekh S, et al. Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination. Leukemia. 2019. PMID: 31439945. doi:10.1038/s41375-019-0519-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。